ONCY

Bullish

Analysts Offer Insights on Healthcare Companies: Enliven Therapeutics (ELVN) and Oncolytics Biotech (ONCY)

LifeSci Capital reiterated a Buy rating for Enliven Therapeutics (ELVN) with a $60.00 price target, highlighting the company's Strong Buy consensus am...

The Globe and Mail 2 days ago 0

Bullish

H.C. Wainwright reiterates Oncolytics Biotech stock rating at buy

H.C. Wainwright has reiterated a Buy rating and a $10.00 price target for Oncolytics Biotech (NASDAQ:ONCY) following a virtual fireside panel discussi...

Investing.com 2 weeks ago 0